# CONFOCAL-2 Interventional Pilot Study

> **NCT07296029** · PHASE1,PHASE2 · COMPLETED · sponsor: **Queen's University** · enrollment: 16 (actual)

## Conditions studied

- Critical Illness
- Respiratory Failure
- Shock
- Delirium

## Interventions

- **DRUG:** Autoregulation-based precision blood pressure management

## Key facts

- **NCT ID:** NCT07296029
- **Lead sponsor:** Queen's University
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-07-29
- **Primary completion:** 2025-02-08
- **Final completion:** 2025-02-08
- **Target enrollment:** 16 (ACTUAL)
- **Last updated:** 2025-12-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07296029

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07296029, "CONFOCAL-2 Interventional Pilot Study". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT07296029. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*